CF is a genetic disease associated with debilitating and terminal lung infections. The bacterial lung pathogen Pseudomonas aeruginosa chronically colonizes the lungs of more than 80% of patients with CF, and its presence is strongly associated with worse patient status. However, it is clear that factors other than the presence of P. aeruginosa impact the rate and extent of lung damage in P. aeruginosa-infected patients. More than a dozen studies have found that fungi also inhabit the lungs of the majority of individuals with CF, published clinical data report correlations between the presence of fungi in culture and worse lung function or increased frequency of disease exacerbations. In two studies, researchers found that patients colonized with both P. aeruginosa and fungi, such as Candida albicans or Aspergillus fumigatus, were worse off than those not co-colonized by fungi. Based on published and preliminary data, we hypothesize that the dynamics between airway bacteria and fungi strongly impact CF lung disease in two ways. First, we hypothesize that the suppression of bacteria during periods of antibacterial therapy leads to high fungal loads that can be harmful to airways (tested in Aim 1). As part of these studies, we will develop methods for the analysis of fungal communities in collaboration with Dr. Mitchell Sogin (MBL) and Dr. Jason Stajich, (UC Riverside) using longitudinally collected clinical samples from patients undergoing systemic antibiotic therapy. In addition to analysis of the changes in fungi species, we will determine if specific fungi increase in absolute levels, how the bacterial communities change in conjunction with changes in the fungal communities, and how fungi impact the host over the course of treatment. Second, we hypothesize that molecular interactions between P. aeruginosa and fungi such as C. albicans and other Candida spp. increase P. aeruginosa virulence in mixed bacterial and fungal infections (tested in Aim 2). We will use a combination of cell culture models and clinical studies, in combination with cutting edge RNA analysis methods, in an iterative process to understand the dynamics of bacteria and fungi in the CF lung. Our long term goals are: (i) to determine if CF patients colonized with fungi would benefit from existing antifungal therapies that are currently only routinely administered to a small subset of CF patients, and (ii) to develop strategies for the analysis of other chronic, polymicrobial infections involving fungi and bacteria, and the interactions that occur between microbes within polymicrobial communities.

Public Health Relevance

Chronic respiratory infections often involve long-term polymicrobial infections involving both bacterial and fungal species. Using respiratory infections associated with the genetic disease cystic fibrosis as a model, our goals are to understand i) how specific bacteria and fungi in the lung impact one another, and ii) if commonly used antibacterial therapies are associated with increases in fungal loads that themselves can be damaging to the host. These studies involve the development and use of state of the art technology for the analysis of polymicrobial communities, and this work has the potential to advance our understanding of the interactions between microbes within other host-associated microbial communities in health and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM108492-01
Application #
8605291
Study Section
Special Emphasis Panel (ZGM1-GDB-2 (MC))
Program Officer
Sledjeski, Darren D
Project Start
2014-02-10
Project End
2017-12-31
Budget Start
2014-02-10
Budget End
2014-12-31
Support Year
1
Fiscal Year
2014
Total Cost
$389,788
Indirect Cost
$122,410
Name
Dartmouth College
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Sakhtah, Hassan; Koyama, Leslie; Zhang, Yihan et al. (2016) The Pseudomonas aeruginosa efflux pump MexGHI-OpmD transports a natural phenazine that controls gene expression and biofilm development. Proc Natl Acad Sci U S A 113:E3538-47
Xie, Jinglin L; Grahl, Nora; Sless, Trevor et al. (2016) Signaling through Lrg1, Rho1 and Pkc1 Governs Candida albicans Morphogenesis in Response to Diverse Cues. PLoS Genet 12:e1006405
Hogan, Deborah A; Willger, Sven D; Dolben, Emily L et al. (2016) Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease. PLoS One 11:e0149998
Hollomon, Jeffrey M; Grahl, Nora; Willger, Sven D et al. (2016) Global Role of Cyclic AMP Signaling in pH-Dependent Responses in Candida albicans. mSphere 1:
Grahl, Nora; Demers, Elora G; Lindsay, Allia K et al. (2015) Mitochondrial Activity and Cyr1 Are Key Regulators of Ras1 Activation of C. albicans Virulence Pathways. PLoS Pathog 11:e1005133
Hogan, Deborah A; Gladfelter, Amy S (2015) Editorial overview: host-microbe interactions: fungi: heterogeneity in fungal cells, populations, and communities. Curr Opin Microbiol 26:vii-ix
Willger, S D; Liu, Z; Olarte, R A et al. (2015) Analysis of the Candida albicans Phosphoproteome. Eukaryot Cell 14:474-85
Hogan, Deborah; Wheeler, Robert T (2014) The complex roles of NADPH oxidases in fungal infection. Cell Microbiol 16:1156-67
Chen, Annie I; Dolben, Emily F; Okegbe, Chinweike et al. (2014) Candida albicans ethanol stimulates Pseudomonas aeruginosa WspR-controlled biofilm formation as part of a cyclic relationship involving phenazines. PLoS Pathog 10:e1004480
Willger, Sven D; Grim, Sharon L; Dolben, Emily L et al. (2014) Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome 2:40

Showing the most recent 10 out of 12 publications